Tango Therapeutics, Inc. (TNGX)
TNGX price $26.37 -0.61 -2.26%
- Ticker
- TNGX
- Price
- $26.37
- Change
- -0.61 -2.26%
- Market cap
- $4.45B
- P/E
- -29.71
- Forward P/E
- 29.44
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 64
Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions…